Biomedical Science Letters

eISSN 2288-7415

Download original image
Fig. 3. Arctigenin increases the Bax/Bcl-2 ratio in SK-BR-3 cells. SK-BR-3 cells were treated with an indicated dose of arctigenin for 24 hours. The cell lysates were subjected to Western blot. (A) The level of Bax and Bcl-2. (B) Each band intensity from the data was normalized to GAPDH and the Bax/Bcl-2 ratio was calculated. Data were presented as mean ± standard error of the mean of three independent experiments and analyzed by Student’s t-test. ***P < 0.001 vs. non-treated control in SK-BR-3 cells.
Biomed Sci Letters 2024;30:209-18 https://doi.org/10.15616/BSL.2024.30.4.209
© 2024 Biomed Sci Letters